Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GDUFA IV: Sponsors May See ANDA Prioritization If Some Production Aspects Onshored
Mar 06 2026
•
By
Derrick Gingery
Domestic manufacturing could be added to the FDA ANDA prioritization MaPP.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from United States